Mar 07, 2024 / 08:00AM GMT
Lars Fruergaard Jorgensen - Novo Nordisk A/S-President - CEO & Member of Management Board
A very warm welcome to the Novo Nordisk 2024 Capital Markets Day. My name is Lars Fruergaard Jorgensen. And together with my management team, I'm very excited about hosting all of you here today. We're excited because of our unprecedented growth. We're excited about the strategies, the progress we're making in building capacity, expanding our pipeline to sustain a very attractive growth going forward. And this is obviously all about serving more patients, and we believe we can serve many more patients in the future. We would like to start the meeting by actually inviting an individual who has been on in one of our trials to learn a bit more about what it means living with obesity and also heart failure.
So [Isabel Davis], please join me here on stage. Please. So Isabel, thank you so much for joining us today and accepting to share a bit with us your experiences. And I would like to ask you by helping us to understand what does it mean to live with obesity and
Novo Nordisk A/S Capital Markets Day Transcript
Mar 25, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers